98 related articles for article (PubMed ID: 10425090)
1. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.
Zhen W; Han H; Anguiano M; Lemere CA; Cho CG; Lansbury PT
J Med Chem; 1999 Jul; 42(15):2805-15. PubMed ID: 10425090
[TBL] [Abstract][Full Text] [Related]
2. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Oxorhenium(V) and Oxotechnetium(V) Complexes That Bind to Amyloid-β Plaques.
Hayne DJ; White JM; McLean CA; Villemagne VL; Barnham KJ; Donnelly PS
Inorg Chem; 2016 Aug; 55(16):7944-53. PubMed ID: 27459001
[TBL] [Abstract][Full Text] [Related]
4. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
Opazo C; Luza S; Villemagne VL; Volitakis I; Rowe C; Barnham KJ; Strozyk D; Masters CL; Cherny RA; Bush AI
Aging Cell; 2006 Feb; 5(1):69-79. PubMed ID: 16441845
[TBL] [Abstract][Full Text] [Related]
5. Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications.
Sagnou M; Benaki D; Triantis C; Tsotakos T; Psycharis V; Raptopoulou CP; Pirmettis I; Papadopoulos M; Pelecanou M
Inorg Chem; 2011 Feb; 50(4):1295-303. PubMed ID: 21250638
[TBL] [Abstract][Full Text] [Related]
6. Oxorhenium(V) and Oxotechnetium(V) Complexes of N
Spyrou B; Hungnes IN; Mota F; Bordoloi J; Blower PJ; White JM; Ma MT; Donnelly PS
Inorg Chem; 2021 Sep; 60(17):13669-13680. PubMed ID: 34424670
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.
Mathis CA; Wang Y; Holt DP; Huang GF; Debnath ML; Klunk WE
J Med Chem; 2003 Jun; 46(13):2740-54. PubMed ID: 12801237
[TBL] [Abstract][Full Text] [Related]
8. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
[TBL] [Abstract][Full Text] [Related]
11. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
12. (99m)Tc-labeled dibenzylideneacetone derivatives as potential SPECT probes for in vivo imaging of β-amyloid plaque.
Yang Y; Cui M; Jin B; Wang X; Li Z; Yu P; Jia J; Fu H; Jia H; Liu B
Eur J Med Chem; 2013 Jun; 64():90-8. PubMed ID: 23644192
[TBL] [Abstract][Full Text] [Related]
13. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
14. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
16. Amyloid imaging: from benchtop to bedside.
Wu C; Pike VW; Wang Y
Curr Top Dev Biol; 2005; 70():171-213. PubMed ID: 16338342
[TBL] [Abstract][Full Text] [Related]
17. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M
Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062
[TBL] [Abstract][Full Text] [Related]
18. Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.
Klunk WE; Jacob RF; Mason RP
Anal Biochem; 1999 Jan; 266(1):66-76. PubMed ID: 9887214
[TBL] [Abstract][Full Text] [Related]
19. 11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
Serdons K; Verduyckt T; Vanderghinste D; Borghgraef P; Cleynhens J; Van Leuven F; Kung H; Bormans G; Verbruggen A
Eur J Med Chem; 2009 Apr; 44(4):1415-26. PubMed ID: 18992967
[TBL] [Abstract][Full Text] [Related]
20. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
